Logo image of LMND

LEMONADE INC (LMND) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:LMND - US52567D1072 - Common Stock

78.97 USD
+2.17 (+2.83%)
Last: 12/5/2025, 8:04:00 PM
79.3 USD
+0.33 (+0.42%)
After Hours: 12/5/2025, 8:04:00 PM
Fundamental Rating

2

Overall LMND gets a fundamental rating of 2 out of 10. We evaluated LMND against 148 industry peers in the Insurance industry. LMND may be in some trouble as it scores bad on both profitability and health. LMND shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

LMND had negative earnings in the past year.
LMND had a negative operating cash flow in the past year.
LMND had negative earnings in each of the past 5 years.
In the past 5 years LMND always reported negative operating cash flow.
LMND Yearly Net Income VS EBIT VS OCF VS FCFLMND Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M -250M

1.2 Ratios

LMND has a worse Return On Assets (-9.06%) than 94.59% of its industry peers.
With a Return On Equity value of -33.67%, LMND is not doing good in the industry: 91.22% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -9.06%
ROE -33.67%
ROIC N/A
ROA(3y)-14.35%
ROA(5y)-14.76%
ROE(3y)-33.95%
ROE(5y)-29.77%
ROIC(3y)N/A
ROIC(5y)N/A
LMND Yearly ROA, ROE, ROICLMND Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

LMND does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LMND Yearly Profit, Operating, Gross MarginsLMND Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

2

2. Health

2.1 Basic Checks

LMND does not have a ROIC to compare to the WACC, probably because it is not profitable.
LMND has more shares outstanding than it did 1 year ago.
The number of shares outstanding for LMND has been increased compared to 5 years ago.
The debt/assets ratio for LMND is higher compared to a year ago.
LMND Yearly Shares OutstandingLMND Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
LMND Yearly Total Debt VS Total AssetsLMND Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

A Debt/Equity ratio of 0.27 indicates that LMND is not too dependend on debt financing.
The Debt to Equity ratio of LMND (0.27) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.77%
LMND Yearly LT Debt VS Equity VS FCFLMND Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.09 indicates that LMND may have some problems paying its short term obligations.
LMND has a better Current ratio (0.09) than 62.16% of its industry peers.
A Quick Ratio of 0.09 indicates that LMND may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.09, LMND is doing good in the industry, outperforming 62.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
LMND Yearly Current Assets VS Current LiabilitesLMND Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.38% over the past year.
Looking at the last year, LMND shows a very strong growth in Revenue. The Revenue has grown by 33.54%.
Measured over the past years, LMND shows a very strong growth in Revenue. The Revenue has been growing by 50.90% on average per year.
EPS 1Y (TTM)21.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.32%
Revenue 1Y (TTM)33.54%
Revenue growth 3Y60.06%
Revenue growth 5Y50.9%
Sales Q2Q%42.39%

3.2 Future

The Earnings Per Share is expected to grow by 19.53% on average over the next years. This is quite good.
LMND is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 37.92% yearly.
EPS Next Y7.97%
EPS Next 2Y17.97%
EPS Next 3Y19.53%
EPS Next 5YN/A
Revenue Next Year36.5%
Revenue Next 2Y49.19%
Revenue Next 3Y40.24%
Revenue Next 5Y37.92%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LMND Yearly Revenue VS EstimatesLMND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
LMND Yearly EPS VS EstimatesLMND Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3 -4

0

4. Valuation

4.1 Price/Earnings Ratio

LMND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LMND. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LMND Price Earnings VS Forward Price EarningsLMND Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LMND Per share dataLMND EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

LMND's earnings are expected to grow with 19.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.97%
EPS Next 3Y19.53%

0

5. Dividend

5.1 Amount

No dividends for LMND!.
Industry RankSector Rank
Dividend Yield N/A

LEMONADE INC

NYSE:LMND (12/5/2025, 8:04:00 PM)

After market: 79.3 +0.33 (+0.42%)

78.97

+2.17 (+2.83%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners57.44%
Inst Owner Change-1.97%
Ins Owners7.12%
Ins Owner Change-0.56%
Market Cap5.90B
Revenue(TTM)658.60M
Net Income(TTM)-173.80M
Analysts52.5
Price Target58.65 (-25.73%)
Short Float %23.37%
Short Ratio5.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.37%
Min EPS beat(2)25.8%
Max EPS beat(2)28.94%
EPS beat(4)4
Avg EPS beat(4)24.29%
Min EPS beat(4)10.83%
Max EPS beat(4)31.6%
EPS beat(8)8
Avg EPS beat(8)19.82%
EPS beat(12)12
Avg EPS beat(12)18.01%
EPS beat(16)15
Avg EPS beat(16)16%
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.32%
Max Revenue beat(2)3.35%
Revenue beat(4)4
Avg Revenue beat(4)1.6%
Min Revenue beat(4)0.32%
Max Revenue beat(4)3.35%
Revenue beat(8)7
Avg Revenue beat(8)1.47%
Revenue beat(12)11
Avg Revenue beat(12)3.41%
Revenue beat(16)15
Avg Revenue beat(16)3.66%
PT rev (1m)10.93%
PT rev (3m)12.47%
EPS NQ rev (1m)1.22%
EPS NQ rev (3m)2.95%
EPS NY rev (1m)0.26%
EPS NY rev (3m)1.9%
Revenue NQ rev (1m)1.21%
Revenue NQ rev (3m)1.21%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.96
P/FCF N/A
P/OCF N/A
P/B 11.43
P/tB 12.07
EV/EBITDA N/A
EPS(TTM)-2.39
EYN/A
EPS(NY)-1.73
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS8.81
BVpS6.91
TBVpS6.54
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.06%
ROE -33.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.35%
ROA(5y)-14.76%
ROE(3y)-33.95%
ROE(5y)-29.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.91%
Cap/Sales 1.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z N/A
F-Score4
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)58.6%
Cap/Depr(5y)137.73%
Cap/Sales(3y)2.62%
Cap/Sales(5y)3.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.32%
EPS Next Y7.97%
EPS Next 2Y17.97%
EPS Next 3Y19.53%
EPS Next 5YN/A
Revenue 1Y (TTM)33.54%
Revenue growth 3Y60.06%
Revenue growth 5Y50.9%
Sales Q2Q%42.39%
Revenue Next Year36.5%
Revenue Next 2Y49.19%
Revenue Next 3Y40.24%
Revenue Next 5Y37.92%
EBIT growth 1Y13.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.15%
EBIT Next 3Y30.28%
EBIT Next 5Y27.77%
FCF growth 1Y76.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.22%
OCF growth 3YN/A
OCF growth 5YN/A

LEMONADE INC / LMND FAQ

Can you provide the ChartMill fundamental rating for LEMONADE INC?

ChartMill assigns a fundamental rating of 2 / 10 to LMND.


Can you provide the valuation status for LEMONADE INC?

ChartMill assigns a valuation rating of 0 / 10 to LEMONADE INC (LMND). This can be considered as Overvalued.


Can you provide the profitability details for LEMONADE INC?

LEMONADE INC (LMND) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for LMND stock?

The Earnings per Share (EPS) of LEMONADE INC (LMND) is expected to grow by 7.97% in the next year.